Can we afford to pay for future cures?
Pharmaceutical R&D is racing ahead of our health system's ability to adjust payment models, but innovative concepts are finally emerging.
top of page
Vocal.
Search
Ulrich Neumann, MBA MSc MA
Nov 14, 20196 min
Prescription Drug Pricing: “The Times They Are A Changin”
The drug pricing debate in DC has intensified, and the pharmaceutical industry has become the prime target of bipartisan outrage.
Ulrich Neumann, MBA MSc MA
Oct 9, 201910 min
'ICER' strikes again - Scandal time?
The drug-price watchdog ICER just issued a "Report on Unsupported Price Increases". The 'study' made the headlines, but it is problematic.
Ulrich Neumann, MBA MSc MA
May 31, 20195 min
Real World Evidence: From Market Access to Drug Approval
This analysis outlines recent developments in the use of real-world evidence (RWE) and the sizeable impact it stands to make the industry.
Ulrich Neumann, MBA MSc MA
Feb 3, 20184 min
Blockchain in Pharma... Blockchain for Market Access? - 5 Thoughts
5 observations as to where we are today, and what might lie ahead for Blockchain in Pharmaceutical Market Access.
Directly blog
bottom of page